期刊文献+

成人隐匿性自身免疫糖尿病患者白蛋白尿的相关因素分析

下载PDF
导出
作者 王晓华
出处 《临床荟萃》 CAS 2009年第23期2067-2068,共2页 Clinical Focus
基金 湖南省医药卫生科研基金(B2005166)
  • 相关文献

参考文献9

  • 1Tuomi T, Groop I.C, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with non-insulin dependent onset of disease[J]. Diabetes, 1993,42(2) :359-362.
  • 2Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis(latent autoimmune diabetes of the adult) [J]. Diabetes Care,2001,24(8) :1460-1467.
  • 3周智广,伍汉文.成人隐匿性自身免疫性糖尿病的诊断与治疗[J].中华内分泌代谢杂志,1998,14(1):1-2. 被引量:98
  • 4Isomaa B,Tuomi T, Almgren P, et al. Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA) [J].Diabetes Care, 1999,22(8) : 1347-1353.
  • 5吴艺捷,赵立,胡远峰,张洪德,董维平.成人迟发自身免疫性糖尿病与1、2型糖尿病临床表现的比较[J].中国糖尿病杂志,2002,10(4):212-215. 被引量:7
  • 6Arikan E, Sabuncu T, Ozer EM, et al. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus [J ]. J Diabetes Complications,2005,19(5) :254-258.
  • 7Bakria GL, Weir MR, Schanifar S, et al. Effects of blood pressure level on progression of diabetic nepbropathy results from the RENAAL study[J]. Arch Intern Med,2003,163(13) : 1555-1565.
  • 8陆宗良.糖尿病患者血脂异常的治疗[J].中国糖尿病杂志,2007,15(1):2-4. 被引量:41
  • 9何冰,韩萍,吕先科.2型糖尿病患者急性时相蛋白与糖尿病肾病的关系[J].中华内分泌代谢杂志,2003,19(4):260-262. 被引量:170

二级参考文献19

  • 1血脂康调整血脂对冠心病二级预防研究协作组.中国冠心病二级预防研究[J].中华心血管病杂志,2005,33(2):109-115. 被引量:220
  • 2罗敏.加强对成人晚发自身免疫性糖尿病的研究[J].中华内科杂志,1997,36(3):151-152. 被引量:23
  • 3Cabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999,340:448-454.
  • 4Donald E. Increased levels of acute-phase serum proteins in diabetes. Metabolism, 1989,38:1042-1046.
  • 5Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system. Diabetologia, 1998,41:1241-1248.
  • 6Martin A, Crook P, John C, et al. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes. Diabetes Care, 2001,24:316-321.
  • 7Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res, 1999,85:753-766.
  • 8Erbagei A, Tarakcioglu M, Coskum Y, et al. Mediators of inflammation in children with type 1 diabetes mellitus: cytokines in type 1 diabetic children. Clin Biochem, 2001,34:645-650.
  • 9Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as disease of the innate immune system: association of acute reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997,40:1286-1292.
  • 10Robins SJ,Collins D,Rubins HB.Relation of baseline lipids and lipid changes with gemfibrozil to cardiovascular endpoints in The VA-High-Density Lipoprotein Intervention Trial (VA-HIT).Circulation,1999,100(suppl I).

共引文献310

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部